PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland. Electronic address: dcorti@vir.bio.\', \'Vir Biotechnology, St. Louis, MO 63110, USA.\', \'Vir Biotechnology, San Francisco, CA 94158, USA.\', \'Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0092-8674(21)00602-410.1016/j.cell.2021.05.005
?:doi
?:hasPublicationType
?:journal
  • Cell
is ?:pmid of
?:pmid
?:pmid
  • 34087172
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 25.137
?:rankingScore_hIndex
  • 682
is ?:relation_isRelatedTo_publication of
?:title
  • Tackling COVID-19 with neutralizing monoclonal antibodies.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34087172>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34087172>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all